Stock RENB RENOVARO INC.
Add to a list
To use this feature you must be a member
Log inSign up

Press Releases Renovaro Inc.

Equities

RENB

US29350E1047

Real-time Estimate Cboe BZX
Other stock markets
 02:31:34 2024-06-06 pm EDT 		5-day change 1st Jan Change
1.34 USD -5.63% Intraday chart for Renovaro Inc. -8.84% -57.73%
May. 24 Renovaro, Amsterdam UMC Cancer Center Plan to Form Joint Venture for Cancer Immunotherapy MT
May. 24 Renovaro Inc. and Amsterdam UMC Cancer Center Poised to Advance Cancer Immunotherapy CI

Press Releases

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Renovaro Inc. and Amsterdam UMC Cancer Center Poised to Advance Cancer Immunotherapy
GL
Renovaro : Material Event - Form 8-K
PU
Transforming Cancer Detection: RenovaroCube Introduces Flamingo, a novel AI model based on Fragmentomics
GL
Transforming Cancer Detection: RenovaroCube Introduces Flamingo, a novel AI model based on Fragmentomics
AQ
RENOVARO - RENOVAROCUBE TO ACQUIRE 100% OWNERSHIP OF CYCLOMICS, REINFORCING CUTTING-EDGE CANCER DIAGNOSTICS PARTNERSHIP
AQ
RenovaroCube to Acquire 100% Ownership of Cyclomics, Reinforcing Cutting-Edge Cancer Diagnostics Partnership
GL
Renovaro Inc. Proudly Announces the Appointment Of Professor Dr. Geert Kazemier as the Chairman of its Scientific Advisory Board, A Move That Heralds a New Era of Innovation and Progress in its Mission to Reshape Cancer Screening, Diagnosis, and Patient Care
GL
Pomerantz Law Firm Investigates Claims On Behalf of Investors of Renovaro Biosciences Inc. - RENB
PR
Pomerantz Law Firm Investigates Claims On Behalf of Investors of Renovaro Biosciences Inc. - RENB
PR
ROSEN, LEADING INVESTOR COUNSEL, Encourages Renovaro Biosciences Inc. Investors to Inquire About Securities Class Action Investigation - RENB
PR
Pomerantz Law Firm Investigates Claims On Behalf of Investors of Renovaro Biosciences Inc. - RENB
PR
ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Renovaro Biosciences Inc. Investors to Inquire About Securities Class Action Investigation - RENB
PR
Pomerantz Law Firm Investigates Claims On Behalf of Investors of Renovaro Biosciences Inc. - RENB
PR
Cutting Edge AI Company GEDiCube and Cyclomics sign binding LOI to join forces and position themselves at the forefront of the global liquid biopsy marketplace
GL
Statement of Renovaro Inc
GL
ROSEN, A LEADING NATIONAL FIRM, Encourages Renovaro Biosciences Inc. Investors to Inquire About Securities Class Action Investigation – RENB
BU
Cutting Edge AI Company GEDiCube and Cyclomics sign binding LOI to join forces and position themselves at the forefront of the global liquid biopsy marketplace
GL
AI Pioneer GEDi Cube and Biotech Innovator Renovaro Biosciences Combine Forces to Accelerate Personalized Medicine
GL
Renovaro Biosciences Announces Results of Special Meeting of Shareholders
GL
Renovaro Biosciences Announces Results of Special Meeting of Shareholders
AQ
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. RENB Stock
  4. News Renovaro Inc.
  5. Press Releases